DetellaDx develops an early detection technology to diagnose ovarian cancer at Stage I when treatment can be curative.
| Website | http://www.detelladx.com |
| Employees | 6 (4 on RocketReach) |
| Founded | 2025 |
| Industry | Biotechnology Research |
Looking for a particular DetellaDx employee's phone or email?
Kellie Bickel is the Co-Founder of DetellaDx.
4 people are employed at DetellaDx.